Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Amortizatization of Intangibles (2024)

Kiora Pharmaceuticals (KPRX) has disclosed Amortizatization of Intangibles for 1 consecutive years, with $77017.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Amortizatization of Intangibles changed N/A year-over-year to $77017.0, compared with a TTM value of $194969.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $283474.0, changed N/A over the prior year.
  • Amortizatization of Intangibles was $77017.0 for Q4 2024 at Kiora Pharmaceuticals, down from $117952.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $117952.0 in Q3 2024 and bottomed at $77017.0 in Q4 2024.